4 results on '"Antonino Vallone"'
Search Results
2. Gender Differences in the Development of CMR Abnormalities and Cardiac Complications: A Multicentric Prospective Study in a Large Cohort of Thalassemia Major Patients
- Author
-
Lucia De Franceschi, Crocetta Argento, Angela Ciancio, Laura Pistoia, Massimiliano Missere, Antonella Meloni, Maurizio Mangione, Alessia Pepe, Silvia Maffei, Antonino Vallone, Giovanni Palazzi, and Vincenzo Positano
- Subjects
medicine.medical_specialty ,business.industry ,Thalassemia ,Immunology ,02 engineering and technology ,Cell Biology ,Hematology ,medicine.disease ,Biochemistry ,Pulmonary hypertension ,Large cohort ,Surgery ,Biventricular function ,020210 optoelectronics & photonics ,Internal medicine ,Heart failure ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,Cardiology ,Myocardial fibrosis ,Multislice ,business ,Prospective cohort study - Abstract
Introduction. We aimed to prospectively assess if the male gender was associated with an higher risk of progressive cardiac iron accumulation, development of biventricular dysfunction and myocardial fibrosis assessed by CMR, and development of cardiac complications including heart failure (HF), arrhythmias and pulmonary hypertension (PH). Methods. We considered 1711 TM patients (899 females, 31.09±9.08 years), consecutively enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network. Myocardial iron overload was assessed by the multislice multiecho T2* technique. Biventricular function was quantified by cine images. Late gadolinium enhancement (LGE) images were acquired to detect myocardial fibrosis. Results. Although having a similar risk of accumulating iron, males showed a significant higher risk of developing cardiac dysfunction, heart failure, arrhythmias and cardiac complications globally considered (Table 1). Figure 1 shows the Kaplan-Meier curves for the outcomes for which the male sex was a significant prognosticator. Until 20-30 years of follow-up the two lines (male and female sex) were almost overlapping while after they clearly diverged. So, patients were divided in two groups based on the follow-up duration. A significant gender-specific difference in the frequency of ventricular dysfunction and cardiac complications appeared for patients followed for at least 20 years. So, two subgroups of patients were identified: patients followed for less than 20 years and patients followed for more than 20 years. In the first subgroup males and females had a comparable risk of developing cardiac iron overload, ventricular dysfunction and cardiac complications. Conversely, if a follow-up longer than 20 years was considered, males exhibited a significant higher risk of having ventricular dysfunction, heart failure, arrhythmias, and cardiac complications. Conclusion. Females seem to tolerate iron toxicity better, possibly as an effect of reduced sensitivity to chronic oxidative stress. According to the International Guidelines, TM patients should perform a complete cardiac evaluation every year. Our study suggested that in females older than 20 years the follow-up may be performed every 24 months, thus reducing health care costs. Table 1 Table 1. Figure 1 Figure 1. Disclosures Pepe: Chiesi Farmaceutici and ApoPharma Inc.: Other: Alessia Pepe is the PI of the MIOT project, that receives no profit support from Chiesi Farmaceutici S.p.A. and ApoPharma Inc.. De Franceschi:F. Hoffmann-La Roche Ltd, Basel, Switzerland: Research Funding.
- Published
- 2016
3. Left Ventricular Global Function Index and Left Ventricular Mass Volume Ratio By CMR: Relation with Heart Failure in Thalassemia Major Patients
- Author
-
Giovan Battista Ruffo, Roberto Sarli, Lucia De Franceschi, Domenico Maddaloni, Sabrina Carollo, Antonella Meloni, Carlo Cosmi, Maria Chiara Resta, Maria Giovanna Neri, Vincenzo Positano, Antonino Vallone, and Alessia Pepe
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Thalassemia ,Immunology ,Diastole ,Magnetic resonance imaging ,Retrospective cohort study ,Cell Biology ,Hematology ,Steady-state free precession imaging ,Stroke volume ,medicine.disease ,Biochemistry ,Heart failure ,Internal medicine ,Global function ,medicine ,Cardiology ,business - Abstract
Introduction: Recently two novels indicators of left ventricular (LV) performance assessed by Cardiovascular Magnetic Resonance (CMR) have been introduced: the LV global function index (LVGFI) and the LV mass/volume ratio (LVMVR). The LVGFI combines LV stroke volume, end-systolic and end diastolic volumes, as well as LV mass, integrating structural as well as mechanical behaviour. Elevated LVMVR is indicative of concentric remodelling. A LVGFI 1 were shown to be associated with the occurrence of cardiovascular events in no-thalassemic populations. This retrospective cohort study aimed to systematically evaluate in a large historical cohort of thalassemia major (TM) in the CMR era whether the LVGFI and the LVMVR were associated with a higher risk of heart failure. Methods: We considered 812 TM patients (391 M, 30.4±8.6 years), consecutively enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) network. LVGFI and LVMRI were quantitatively evaluated by SSFP cine images. The T2* value in all the 16 cardiac segments was evaluated and a global heart T2* value Results: Eighty (9.9%) patients had a LVGFI Thirty (3.7%) patients had a LVMVR≥1% and, compared to the patients with a normal LVMRI, they showed a significant higher frequency of heart failure (20.0% vs 7.7%; P=0.015). Patients with a LVMVR≥1% had a significant higher risk of heart failure (OR=3.01, 95%CI=1.18-7.64; P=0.021). The risk remained significant also adjusting for the presence of MIO (OR=3.44, 95%CI=1.31-9.01; P=0.012). In a multivariate model including LVGFI, LVMVR and heart iron, the significant predictors of heart failure were a LVGFI Conclusions: In TM patients a LVGFI Disclosures No relevant conflicts of interest to declare.
- Published
- 2014
4. Hypothyroidism and Cardiac Complications In Thalassemia Major Patients
- Author
-
Giuseppina Secchi, Antonino Vallone, Maria Rita Gamberini, Giuseppe Rossi, Antonella Meloni, Massimo Lombardi, Alfonso D'Ambrosio, Stefano Pulini, Alessia Pepe, Silvia Macchi, and Lucia De Franceschi
- Subjects
endocrine system ,education.field_of_study ,medicine.medical_specialty ,Ejection fraction ,endocrine system diseases ,business.industry ,Immunology ,Population ,Cardiac index ,Retrospective cohort study ,Cell Biology ,Hematology ,Odds ratio ,Stroke volume ,medicine.disease ,Biochemistry ,Pulmonary hypertension ,Heart failure ,Internal medicine ,Cardiology ,Medicine ,business ,education - Abstract
Introduction In the non-thalassemic population hypothyroidism has been associated with an increased risk of cardiac disease while the link thyroid-heart disease has been little explored in thalassemia major (TM). This retrospective cohort study aimed to systematically evaluate in a large historical cohort of TM in the cardiovascular magnetic resonance (CMR) era whether hypothyroidism was associated with a higher risk of heart complications (heart failure, arrhythmias and pulmonary hypertension). Methods From a cohort of 957 TM patients who underwent CMR for myocardial iron overload (MIO) assessment, quantification of biventricular function and detection of myocardial fibrosis within the MIOT network (Myocardial Iron Overload in Thalassemia), we identified 115 (12%) hypothyroid patients. Each hypothyroid patient was matched by sex and age (at the time of the CMR) with two non-hypothyroid patients, creating 115 triples. A cardiac event was considered valid if diagnosed at an age older than the hypothyroidism’s onset age for the hypothyroid patient in the belonging triple. Results Hypothyroid and non-hypothyroid patients had comparable MIO, but hypothyroid patients showed significantly lower biventricular stroke volume index, ejection fraction and left ventricular cardiac index. Accordingly, the prevalence of overall heart dysfunction (LV, RV or both) was higher in hypothyroid patients (43.5% vs 33.5%, P=0.0314). Hypothyroid patients had a significant higher frequency of heart failure (19.1% vs 9.1%, P=0.003) and arrhythmias (11.3% vs 4.3%; P=0.003). Figure1 shows odds ratios (OR) estimating the relationship between hypothyroidism and cardiac involvement. Hypothyroid patients had a significant higher risk of heart dysfunction, heart failure and arrhythmias, also adjusting for the endocrine co-morbidity. Conclusions Hypothyroidism seems to increase the risk for heart failure, arrhythmias and heart dysfunction in TM patients. Our data confirm the link thyroid-heart disease also in TM patients and they stress the need to prevent hypothyroidism in this population. Disclosures: No relevant conflicts of interest to declare.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.